Cardiac Success

Cardiac Success Overview

Cardiac Success is developing the V-sling, a device designed to improve the lives of millions of patients who, despite guidance-directed medical therapy, continue to experience deterioration from heart failure with reduced ejection fraction (HFrEF). The V-sling is a transcatheter ventricular repair device with a design based on a successful surgical papillary muscle approximation procedure.

Cumulative Funding Raised Over Time ($)

Latest News

Jun 24, 2021 · www.finsmes.com

growth-positive

Cardiac Success Closes US $5.2M Series A Financing

Cardiac Success, a medical device startup, has closed a US $5.2M Series A financing round led by 415 Capital. The company will use the funds for pre-clinical testing and the completion of a First-in-Human trial for its V-sling heart failure therapy. The V-sling system aims to transform an invasive open-heart surgery into a minimally-invasive transcatheter procedure and treats left ventricular dysfunction. Cardiac Success has 4 granted US patents and additional patents pending in the US, Europe, and other countries. The company was founded in 2017 and is led by CEO Boaz Manash.

Investment

Funding

Team Members

2

Employees: 1-10

Web & Social Links

Locations

Yokne'am Illit, Israel

Photos & Videos

1 item(s)

Cardiac Success Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info